Research team

Developed and validated by a network of private and public institutes

 Institutions involved:

• Bayer-Schering AG
• Free University Berlin
• Institute of Sexology and Sexual Medicine, Charité – Universitätsmedizin Berlin
• MSD
• Solvay Pharmaceuticals
• TNS-Infratest, Munich
• University of Muenster
• University of Berlin
• ZEG Berlin

Research teams involved:

• Belgium (MAPI)
• Latvia (MAPI)
• Brazil (Carmita Abdo)
• Lebanon (Patrick Choueiry)
• Bulgaria (Philipp Kumanov)
• Malaysia (Geeta Appannah)
• Chile (Alide Salazar Molina)Mongolia (Munkhtsetsek Janlav)
• China (Yi Qun Gu)
• Nigeria (Akinyemi Akanni)
• Croatia (Sandra N. Sprajc, Claire Pexman-Fieth)
• Norway (Johan Svartberg)
• Denmark (MAPI)
• Netherlands (Annoesjka Novak)
• Netherlands (MAPI)
• Poland (MAPI)
• English UK/USA (Lothar Heinemann, Karin Thiele)
• Portugal (Peter Potthoff)
• Finland (Marc Renard )
• Romania (Dessislava Groseva, Claire Pexman-Fieth)
• France (MAPI, Eric Myon)
• Russia (MAPI)
• Germany (Lothar Heinemann)
• Slovenia (Jaro Lajovic, Claire Pexman-Fieth)
• Hungary (Cziszer Robert, Claire Pexman-Fieth)
• Spain (Xavier Badia, Peter Potthoff)
• Indonesia (Akmal Taher)
• Sweden (Peter Potthoff)
• Italy (Giorgio Valenti, Paolo Gontero)
• Taiwan (Ching-Yen Chen)
• Japan (Naoki Itho)
• Thailand (Somboon Leungwattanakij)
• Korea (Sehyun Kim)
• Turkey (Onder Canguven)